That is very important, due to the fact that the way a protein in the human body folds figures out if a pharmaceutical will be able to bind to that protein and work. In other words, we have to know how these proteins fold if we want a drug to work. Historically, this has been a trial-and-error process (tech stock). Today, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it a lot easier to produce drugs that do what they're developed to do. This was a development nearly nobody noticed. However it's going to have extensive ramifications for treating disease. I predict that Alpha, Fold will be 98% accurate by the end of 2021.
And, obviously, there will be a lot of financial investment chances in this space, too. Shifting topics It's going to be a great year for bitcoin. I'm bullish on it in 2021 (jeff brown top stock pick 2021). That stated, I still believe bitcoin will continue to be unpredictable. We're close to all-time highs. I would not be amazed if it drew back perhaps substantially before going higher - white house. I've been covering bitcoin for a long period of time now. One of the very first research reports I ever released was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that initial recommendation, I entitled my report "What's the Big Deal With Bitcoin?" That shows you where the conversation was at the time. We were mainly informing readers. But that's not the huge concern anymore. Now we're seeing institutional cash finally take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, specific niche business. Mass, Mutual is a trusted 170-year-old institution. So consider that. In 5 years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
Which's a big reason I'm bullish on it this year. legacy report prediction. Regards, Jeff Brown, Editor, The Bleeding Edge I have a benefit prediction 2020 was a record year for IPOs. 552 U.S. business went public the most in more than 20 years. These companies raised a total of $172 billion. That's an all-time high beating the previous annual record by 43%. I predict 2021 will be another record year in IPOs. There are many great private business on the edge of striking the general public markets And I've been working on a brand-new way for you to invest even before these companies go public.
This opportunity has actually been developing over the last couple of years. I can't wait to tell you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to discover all the information. Go right here to reserve your area totally free.
Emma Walsh here, managing editor of the Diary. Regular Journal readers understand that tech isn't our normal beat (tech stock). And when it comes to tech investing, we leave it to the professionals. Thankfully, we have numerous such experts in our Rolodex. Our colleague Jeff Brown will be familiar to our long time readers. He is one of the most accomplished tech investing experts we understand (jeff brown stock predictions). In truth, he had a number of triple-digit returns in his Brownstone Research study portfolios in 2015. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to have a look at the big image and predict what's just around the corner.
That includes things like 5G networks, biotech, artificial intelligence, and much more. These patterns are experiencing exponential development and creating amazing opportunities for financiers. I wish to ensure all our readers are gotten ready for what's next. And with that in mind, let me draw the image of what I see being available in the next 12 months Our new 5G (fifth-generation) cordless networks are a topic I've been covering for years now. the legacy report prediction. However regardless of what numerous readers might think, this is a trend that's just starting. Even though the COVID-19 pandemic interrupted supply chains last year, an excellent 250 million 5G-enabled gadgets were still offered.
And all of this eventually caused Apple postponing the release of the 5G-enabled i, Phone 12 by 2 months (biotech stocks jeff brown). Losing two months of manufacturing and sales actually affects how numerous 5G gadgets are sold in the fiscal year. When you think about all of that, selling 250 million units is exceptional. More notably, the delays triggered by the pandemic produced a lots of pent-up need. And that need is now going to be pushed into 2021. In reality, I anticipate that more than 500 million 5G gadgets will be shipped in 2021 - jeff brown stock predictions 2021. Which's not my only 5G prediction When I have actually spoken about 5G in the past, I've described its three different phases.
In Stage Two, 5G gadgets go on sale. 5G phones and other items start to reach customers. And in Stage 3, 5G services start to be offered (exponential growth). That's when we begin to see applications operating on 5G networks. Think about things like massive multiplayer video games over a mobile phone. That's not possible with 4G. It will be with 5G. And my second 5G forecast for 2021 is that we will begin Phase 3 by this summer. This begins something of a virtuous cycle: The majority of people don't really care about the technology. But they will care if there are amazing applications that can only be accessed with a 5G phone.
That results in more 5G apps being established. In reality, 5G is going to open a suite of amazing applications: self-driving automobiles, the Web of Things, robotic surgical treatment, and more. All of these technologies require 5G. The financial investment chances going forward will be huge. Stepping away from 5G, the next important innovation I anticipate in 2021 is CRISPR hereditary modifying. CRISPR means "clustered regularly interspaced short palindromic repeat." It's a mouthful. However it's one of the most exciting developments in biotechnology. At a high level, CRISPR is a technology that can edit our genetic makeup as if it were software.
The program can crash or not function properly. CRISPR utilizes a comparable concept but with our hereditary code. "Typos" in our genome can cause illness. CRISPR can fix these "typos." For years, CRISPR was primarily a specific niche innovation that wasn't well comprehended. And during that time, there were truly just three companies running in this space. However things are changing. CRISPR is no longer simply theoretical. We're seeing actual results. We're treating diseases and seeing that this innovation simply works. And as an outcome, a "second crop" of early-stage CRISPR business is going public and delivering extraordinary returns. This whole industry is successfully a greenfield opportunity.
There's space for many companies to exist in this space. jeff brown biotech genome sequencing. And there will be more. That's my forecast for CRISPR in 2021. I anticipate that two or three more genetic modifying business will hold their IPOs. Sticking with biotechnology, we are seeing amazing things taking place at the convergence of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, just announced at the end of 2020 that its latest Alpha, Fold software can properly forecast the folding of a protein based solely on its amino acid series with 92. 4% precision. That is necessary because the way a protein in the human body folds identifies if a pharmaceutical will have the ability to bind to that protein and work.
Historically, this has been an experimental process. And now, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it much easier to develop drugs that do what they're developed to do. And here's my next prediction. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not just one however numerous drug treatments produced using this innovation. This was one of those breakthroughs that nearly nobody saw. However it's going to have extensive implications for treating illness. And, naturally, there will be lots of financial investment chances in this space, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That said, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be shocked if it pulled back perhaps significantly prior to going higher. I've been covering bitcoin for a very long time now. One of the first research study reports I ever released was on bitcoin - jeff brown biotech stock pick for 2020. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for any person who followed my suggestion. But at the time of that initial recommendation, I entitled my report, "What's the Big Offer With Bitcoin?" That shows you where the conversation was at the time.
But nobody is asking that concern any longer. Now, we're seeing institutional money lastly taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, specific niche business. what is the legacy report predicting. Mass, Mutual is a 150-year-old organization. So consider that. In five years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a huge factor why I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another perk forecast In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown deserves about $27. 5 million and claims the information depends on date since February 2021, but we might not separately validate this claim. Offered Jeff Brown's past, he likely has a significant net worth, however we can't hammer down an accurate figure at this minute. Brown is best understood for his sage-like ability to select winning innovation stocks. He invested more than 25 years researching innovation business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience offers him an exceptional perspective on the marketplace. He's constantly on the hunt for brand-new opportunities, and he shares a lot of his best picks in the Future Report.
That's full marks, but it's not absurdly reasoned. Brown has an outstanding credibility as a stock-picker, and he successfully forecasted a few of the most significant financial occasions of the previous twenty years. Although he does not appear to release his choices to the general public, the service's success is a direct indication of Brown's stock-picking expertise. Nobody on Wall Street gets it right each time, but Jeff Brown's precise predictions have actually earned him legions of dedicated fans. That says a lot about his capability. The Future Report is released by Brownstone Research, a prominent financial research study publisher. Brownstone Research offers numerous research services with a wide range of expertises - jeff brown predictions for 2021.
The business is also associated with Bonner & Partners, another well-respected research publisher - future report review. On its website, Brownstone states its objective is to supply retail financiers with professional-grade research: "For too long, the finest financial investment research study has not been offered to private investors. It has actually been usually booked for financial investment banks, hedge funds, private equity, and high-net-worth clients. brownstone research. The mission of Brownstone Research study is to make that type of exclusive research readily available to any financiers looking to gain an edge in the markets. The goal is simple to deliver distinct and successful financial investment research study found no place else." -Brownstone Research study site excerpt from the Jeff Brown is the founder of Brownstone Research, and he also functions as the firm's Chief Investment Analyst.
With Brown guiding the ship, Brownstone Research is a powerhouse publisher with lots to provide its customers. After decades of constant success at the helm of top-tier business like Tesla and Area, X, Elon Musk is a household name throughout many of America. If you understand even a bit about the market, you know that he has a reputation as a King Midas of sorts. jeff brown investment prediction. Everything he touches turns to gold! Jeff is well mindful of Elon Musk's executive expertise, so he constantly has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next big job.
In fact, Brown thinks S.A.V. jeff brown biotech stock. might be "the biggest pattern of the 2020s, and he's not alone. Inspect out these quotes from other widely known S.A.V. bulls: Elon's next huge act will be weding two innovative technologies: artificial intelligence and electric vehicles. Musk hopes the mix will help him establish the first fully-autonomous, self-driving cars and trucks ever. It's absolutely nothing short of the automobile industry's Holy Grail. As you understand, electrical lorries and self-driving cars and truck stocks have actually been big this year, but the Wall Street device has been big on hype without much concrete outcome. Despite an extreme boost in competitors over the previous few years, Brown still thinks Musk has the finest possibility of putting all of it together.
tech might be the magic string that ties all of it together. S.A.V. stands for Shared Autonomous Vehicle, and it might be the future of transport. Basically, this technology would enable you to rent your car as an autonomous, self-driving taxi when you're not using it. You simply leave the cars and truck and press a button on an app that informs the car to "join the fleet." Next thing you understand, you're relaxing on your couch while your vehicle shuttles ride-sharers around town. Best of all, you get to keep a hefty chunk of the earnings. It sounds insane, however it could be closed than you think.